HCAIX-IN-23
Product Specifications
Target
Carbonic Anhydrase|||Apoptosis|||Ferroptosis|||Reactive Oxygen Species|||Caspase|||Mitochondrial Metabolism
Related Pathways
Immunology/Inflammation|||NF-?B|||Metabolism|||Apoptosis|||Proteases/Proteasome
Bioactivity
HCAIX-IN-23 (Compound 27) is a human carbonic anhydrase (hCA) inhibitor with Ki values of 10.4 nM for hCA IX and 8.5 nM for hCA XII. It not only inhibits hCA activity but also releases NO, exerting dual anti-tumor effects. By reducing the expression of hCA IX and iron regulatory proteins, hCAIX-IN-23 regulates mitochondrial caspase activity and the ferroptosis pathway, thereby inducing apoptosis. This compound is utilized in research focused on renal cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/250676858465550391/T200575
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
